Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Thank you. I remember you. Good luck to you.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sage4 Member Profile
 
Followed By 29
Posts 2,776
Boards Moderated 0
Alias Born 02/21/11
160x600 placeholder
Clearside Biomedical, Eloxx Pharmaceuticals leads healthcare gainers; PDS Biotechnology, Sage Therapeutics among major losers Seeking Alpha - 6/15/2021 11:02:54 AM
Anavex Life outlines mechanism of ANAVEX2-73 and ANAVEX3-71 in treatment of Alzheimer's Disease Seeking Alpha - 6/14/2021 8:41:57 AM
Anavex Life Sciences Reports New Publication in Medical Journal Elucidating the Mechanism of ANAVEX®2-73 (blarcamesine) and ... GlobeNewswire Inc. - 6/14/2021 7:00:00 AM
Anavex Life Sciences Announces Exceeding of Enrollment Target for the Precision Medicine ANAVEX®2-73 (blarcamesine) Phase 2b... GlobeNewswire Inc. - 6/8/2021 7:00:00 AM
CEO's Presenting at Emerging Growth Conference Virtually Tomorrow InvestorsHub NewsWire - 6/8/2021 7:00:00 AM
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application ANAVEX®2-73 (blarcamesine) for the Treatment ... GlobeNewswire Inc. - 6/3/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2021 4:02:36 PM
Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors GlobeNewswire Inc. - 5/26/2021 7:00:00 AM
CEO's Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/24/2021 7:03:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/19/2021 8:48:29 AM
Anavex Life Sciences EPS beats by $0.03 Seeking Alpha - 5/13/2021 7:11:29 AM
Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook GlobeNewswire Inc. - 5/13/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit GlobeNewswire Inc. - 5/7/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 Second Quarter Financial Results and Business Outlook on Thursday, May 13, 2021 GlobeNewswire Inc. - 5/6/2021 7:00:00 AM
Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President for Nonclinical Development GlobeNewswire Inc. - 5/5/2021 7:00:00 AM
Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference GlobeNewswire Inc. - 4/26/2021 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/12/2021 4:06:51 PM
Anavex Life Sciences Reports the Results of Review by the Independent Data Safety Monitoring Board for its Phase 2/3 Trials o... GlobeNewswire Inc. - 4/12/2021 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/9/2021 5:07:26 PM
Anavex Life Sciences to Present at the 20th Annual Needham Virtual Healthcare Conference GlobeNewswire Inc. - 4/8/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming World EPA - Evidence, Pricing and Access - Congress 2021 GlobeNewswire Inc. - 4/7/2021 7:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/1/2021 4:14:18 PM
DSMB recommends continuation of Anavex Life's late-stage Alzheimer’s study Seeking Alpha - 3/31/2021 7:14:03 AM
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of... GlobeNewswire Inc. - 3/31/2021 7:00:00 AM
Anavex Life Sciences Reports ANAVEX®2-73 (blarcamesine) featured as a Disease-Modifying Small Molecule in Phase 3 Clinical T... GlobeNewswire Inc. - 3/16/2021 7:00:00 AM
sage4   Thursday, 02/04/21 02:32:15 AM
Re: Millstone post# 296038
Post # of 314773 
Thank you. I remember you.
Good luck to you.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences